ArticleFrontiers in molecular biosciences2026
Integrated transcriptome and single-cell RNA sequencing identifies transient receptor potential channel-related biomarkers in ulcerative colitis.
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The precise cause of ulcerative colitis (UC) is still unclear. While transient receptor potential (TRP) ion channels are increasingly linked to UC pathophysiology, the comprehensive roles of TRP channel-related genes are not well understood. This study aimed to systematically identify TRP channel-related biomarkers and develop novel diagnostic and therapeutic targets for UC. Methods: Transcriptomic data were retrieved from the Gene Expression Omnibus (GEO). Machine learning algorithms were applied to select signature genes from the overlap between differentially expressed genes (DEGs) and a curated set of 111 transient receptor potential (TRP) channel-related genes. A diagnostic nomogram incorporating signature genes was constructed, and its performance was assessed by receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). The cellular landscape was characterized using single-cell RNA sequencing (scRNA-seq) combined with pseudotime trajectory inference and cell-cell communication analysis. Key results were further validated in a dextran sulfate sodium (DSS)-induced murine colitis model by flow cytometry, multiplex immunohistochemistry, western blotting, and quantitative real-time PCR. Results: Five TRP channel-related feature genes (IL-1β, PIK3R3, ADCY3, ADCY7, and TRPV1) were identified. In UC, IL-1β, PIK3R3, ADCY3, and ADCY7 were notably upregulated, while TRPV1 was markedly downregulated. The nomogram, utilizing these five feature genes, exhibited outstanding discriminatory capability (AUC = 0.993) and provided enhanced net clinical benefit. scRNA-seq analysis identified B and plasma cells as the most significantly expanded pathogenic population, exhibiting acquired bidirectional crosstalk with epithelial cells in UC. Pseudotime trajectory analysis revealed that IL-1β and PIK3R3 were mainly concentrated during the initial developmental phases of B and plasma cells. In the DSS-induced colitis model, there was a notable increase in B-cell infiltration, accompanied by significant upregulation of IL-1β and Pik3r3 at both protein and mRNA levels, with confirmed colocalization with Cd19 Conclusion: This study identified five TRP channel-related biomarkers and created a high-performance diagnostic nomogram for UC. The study underscores the pivotal role of B and plasma cells, identifying IL-1β and PIK3R3 as early-activated genes in pathogenic B-cell responses, thus offering new diagnostic biomarkers and therapeutic targets for UC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.